文章摘要
随海田,高汇迪,赵若颖,郭昱,苏锦锋,舒祥.高风险人群流感疫苗接种现况和免疫策略分析[J].中华流行病学杂志,2024,45(4):615-620
高风险人群流感疫苗接种现况和免疫策略分析
Analysis of influenza vaccination status and immunization strategy in high-risk population
收稿日期:2023-07-18  出版日期:2024-04-17
DOI:10.3760/cma.j.cn112338-20230718-00016
中文关键词: 流感  临床风险人群  免疫策略
英文关键词: Influenza  Clinical risk groups  Immunization strategy
基金项目:
作者单位E-mail
随海田 中国生物技术股份有限公司, 北京 100024  
高汇迪 中国生物技术股份有限公司, 北京 100024  
赵若颖 中国生物技术股份有限公司, 北京 100024  
郭昱 中国生物技术股份有限公司, 北京 100024  
苏锦锋 中国生物技术股份有限公司, 北京 100024  
舒祥 中国生物技术股份有限公司, 北京 100024 shuxiang1@sinopharm.com 
摘要点击次数: 1176
全文下载次数: 400
中文摘要:
      流感是由流感病毒引起的一种呼吸道传染性疾病,严重疾病负担常见于高风险人群。接种流感疫苗是预防流感及其并发症的有效方法,尤其是对高风险人群。虽然已有部分国家将流感疫苗纳入国家免疫规划,但全球范围内高风险人群流感疫苗接种率仍然较低。目前,流感疫苗在我国仍属于自愿自费接种的非免疫规划疫苗,且全国各地流感疫苗免疫策略差异化明显,接种率与发达国家仍有差距。进一步优化我国流感疫苗全人群免疫策略,加强流感疫苗全人群免疫策略的宣传,降低我国流感的疾病负担,是目前迫切需要解决的问题。
英文摘要:
      Influenza is a contagious respiratory disease caused by influenza viruses, and the burden of severe disease is commonly seen in high risk populations. Influenza vaccination is an effective way to prevent influenza and its complications, especially for high risk populations. Although some countries have included influenza vaccine in their national immunization programs, influenza vaccination rates remain low globally in high risk populations. The influenza vaccine in China is still a non-immunization program vaccine that is voluntarily vaccinated at its own expense, and the influenza vaccine immunization strategy is different across the country. There is still a gap between the vaccination rate of the influenza vaccine and that of developed countries. It is an urgent problem to further optimize the whole population immunization strategy of influenza vaccine in China, strengthen the publicity of the whole population immunization strategy of influenza vaccine, and reduce the disease burden of influenza in China.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭